JobDrop

Adverum Biotechnologies, Inc. jobs

Browse current Adverum Biotechnologies, Inc. openings that JobDrop found directly from the company's careers source.

QC Analyst II/III Reviewer (Contract)

Adverum Biotechnologies, Inc. · Redwood City, CA, US · Posted 2026-05-28 · 3-5 years

Adverum Biotechnologies, Inc., wholly owned subsidiary of Eli Lilly and Company, is a mission-driven clinical-stage company that aims to establish gene therapy as a new standard of care for highly prevalent ocular diseases with the aspiration of developing functional cures to restore vision and prevent blindness. Lever

AnalystIIIReviewerreviewadverumqualitydocumentationanalytical

Senior Scientist, Downstream Process Development (Contract) - AW

Adverum Biotechnologies, Inc. · Redwood City, CA, US · Posted 2026-04-24 · 8+ years

Adverum Biotechnologies, Inc., wholly owned subsidiary of Eli Lilly and Company, is a mission-driven clinical-stage company that aims to establish gene therapy as a new standard of care for highly prevalent ocular diseases with the aspiration of developing functional cures to restore vision and prevent blindness. Lever

ScientistDownstreamProcessDevelopmentadverumgenesupporttherapy

Director, QA Systems (Contract)

Adverum Biotechnologies, Inc. · Redwood City, CA, US · Posted 2026-02-17 · 13+ years

Adverum Biotechnologies, Inc., a wholly owned subsidiary of Eli Lilly and Company is a mission-driven clinical-stage company that aims to establish gene therapy as a new standard of care for highly prevalent ocular diseases with the aspiration of developing functional cures to restore vision and prevent blindness. Leve

DirectorSystemsqualityabilityadverumregulatorycross-functionalinternal

Work with us!

Adverum Biotechnologies, Inc. · Redwood City, CA, US · Posted 2020-10-29

Adverum is a clinical-stage company that aims to establish gene therapy as a new standard of care for highly prevalent ocular diseases with the aspiration of developing functional cures to restore vision and prevent blindness. Leveraging the capabilities of its proprietary intravitreal platform, Adverum is developing d

adverumocularagenciesgenetherapystandardcarediseases